Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Registry of Patients With Psoriatic Disease Receiving Interleukin-23 Inhibitor Therapy Within the Costa Rican Social Security System

NCT07448402 is registered in ClinicalTrials.gov with Caja Costarricense de Seguro Social as lead sponsor.

NCT NCT07448402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Registry of Patients With Psoriatic Disease Receiving Interleukin-23 Inhibitor Therapy Within the Costa Rican Social Security System
Lead sponsor
Caja Costarricense de Seguro Social
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
May 31, 2031
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriasis (pso), psoriasis arthritis